6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $14M | -$9M | 8890.6% | -70.5% | -$17M | — | $8M |
| 2024 | $12M | -$6M | 9148.4% | -40.6% | — | — | $20000 |
| 2023 | $33M | -$9M | 3222.6% | -23.2% | -$2M | $5M | $1M |
| 2022 | $46M | -$14M | 24.6% | -35.6% | -$5M | — | $1M |
| 2021 | $35M | -$6M | 29.8% | -15.2% | — | — | $2M |
| 2020 | $31M | $2M | 27.4% | 3.8% | — | — | $1M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $10M | -$6M | 24.3% | -36.8% | -$7M | $18M | $4M |
| Dec '25 | $3M | -$5M | 5256.5% | -141.5% | -$7M | — | $8M |
| Sep '25 | $3M | -$2M | 0.0% | -74.3% | -$2M | — | $2M |
| Jun '25 | $4M | -$1M | 0.0% | -38.2% | — | — | — |
| Mar '25 | $4M | -$2M | 28887.7% | -37.7% | — | — | $7M |
| Dec '24 | $2M | -$1M | 0.0% | -22.7% | — | — | $20000 |
| Sep '24 | $2M | -$1M | 0.0% | -48.4% | — | — | $28000 |
| Jun '24 | $3M | -$2M | 0.0% | -46.2% | — | — | $29000 |
| Mar '24 | $4M | -$2M | 26040.4% | -41.7% | — | $3M | $301000 |
| Dec '23 | $7M | -$2M | 21.7% | -19.4% | $594000 | $5M | $1M |
| Sep '23 | $8M | -$2M | 21.9% | -19.6% | -$5000 | — | $75000 |
| Jun '23 | $9M | -$2M | 22.8% | -18.7% | -$1M | — | $132000 |
| Mar '23 | $10M | -$3M | 16.2% | -32.6% | -$2M | — | $267000 |
| Dec '22 | $11M | -$5M | 16.1% | -43.9% | — | — | $1M |
| Sep '22 | $12M | -$2M | 28.7% | -18.8% | — | — | $4M |
| Jun '22 | $12M | -$405000 | 27.3% | -12.4% | — | — | $1M |
| Mar '22 | $11M | -$2M | 26.2% | -17.9% | — | — | $2M |
| Dec '21 | $9M | -$3M | 24.7% | -36.3% | — | — | $2M |
| Sep '21 | $8M | -$2M | 33.7% | -21.9% | — | — | $1M |
| Jun '21 | $10M | $304000 | 33.3% | 4.7% | — | — | — |
How the market has priced HCTI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Healthcare Triangle, Inc.'s revenue has declined 15.0% per year. These are computed facts, not advice.
As of FY2025, Healthcare Triangle, Inc. reported — of total debt against $8M of cash; operating income covered interest expense -17.3×.
In FY2025, gross margin was 8890.6%, operating margin -70.5%, and net margin -68.2%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.